EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Candida albicans —A systematic review to inform the World Health Organization Fungal Priority Pathogens List

Sarika Parambath, Aiken Dao iD, Hannah Yejin Kim, Shukry Zawahir, Ana-Alastruey Izquierdo iD, Evelina Tacconelli, Nelesh Govender iD, Rita Oladele iD, Arnaldo Colombo, Tania Sorrell iD, Pilar Ramon-Pardo, Terence Fusire und 5 weitere

Medical Mycology · 27.06.2024 · 62 (6)

DOI: 10.1093/mmy/myae045 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medical Mycology, online erschienen am 27.06.2024. Verfasst von Sarika Parambath und 16 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Infectious Diseases Institute, The University of Sydney, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Candida albicans, Drug Resistance, Fungal, Antifungal Agents. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: World Health Organization, Ministry of Education and Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida albicans is a common fungal pathogen and amongst the leading causes of invasive candidiasis globally. This systematic review examines the characteristics and global impact of invasive infections caused by C. albicans. We searched on PubMed and Web of Science for studies reporting on criteria such as mortality, morbidity, drug resistance, preventability, yearly incidence, and distribution/emergence during the period from 2016 to 2021. Our findings indicate that C. albicans is the most common Candida species causing invasive disease and that standard infection control measures are the primary means of prevention. However, we found high rates of mortality associated with infections caused by C. albicans. Furthermore, there is a lack of data on complications and sequelae. Resistance to commonly used antifungals remains rare. Although, whilst generally susceptible to azoles, we found some evidence of increasing resistance, particularly in middle-income settings—notably, data from low-income settings were limited. Candida albicans remains susceptible to echinocandins, amphotericin B, and flucytosine. We observed evidence of a decreasing proportion of infections caused by C. albicans relative to other Candida species, although detailed epidemiological studies are needed to confirm this trend. More robust data on attributable mortality, complications, and sequelae are needed to understand the full extent of the impact of invasive C. albicans infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida albicansDrug Resistance, FungalAntifungal AgentsHumansWorld Health OrganizationCandidiasisCandidiasis, InvasiveGlobal HealthIncidence

Stichwörter der Autor:innen

Candida albicansantifungal resistanceepidemiologyinvasive candidiasismortality

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Sydney Infectious Diseases Institute, The University of Sydney, Sydney, NSW, Australia.
  • Westmead Institute for Medical Research, Westmead, NSW, Australia.
  • Westmead Hospital, Westmead, NSW, Australia.
  • Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
  • Westmead Hospital, Department of Pharmacy, Westmead, NSW, Australia.
  • Central Clinical School, The University of Sydney Faculty of Medicine and Health, Sydney NSW, Australia.

ORCID-Profile: Aiken Dao, Ana-Alastruey Izquierdo, Nelesh Govender, Rita Oladele, Tania Sorrell, Jan-Willem Alffenaar, Justin Beardsley

Förderung

  • World Health Organization
  • Ministry of Education and Science

Zitieren

APA

Parambath, S., Dao, A., Kim, H. Y., Zawahir, S., Izquierdo, A. A., Tacconelli, E., Govender, N., Oladele, R., Colombo, A., Sorrell, T., Ramon-Pardo, P., Fusire, T., Gigante, V., Sati, H., Morrissey, C. O., Alffenaar, J. W., & Beardsley, J. (2024). Candida albicans —A systematic review to inform the World Health Organization Fungal Priority Pathogens List. Medical Mycology, 62(6). https://doi.org/10.1093/mmy/myae045

Vancouver

Parambath S, Dao A, Kim HY, Zawahir S, Izquierdo AA, Tacconelli E, et al. Candida albicans —A systematic review to inform the World Health Organization Fungal Priority Pathogens List. Medical Mycology. 2024;62(6). doi:10.1093/mmy/myae045

BibTeX
@article{Parambath2024,
  author = {Parambath, Sarika and Dao, Aiken and Kim, Hannah Yejin and Zawahir, Shukry and Izquierdo, Ana-Alastruey and Tacconelli, Evelina and Govender, Nelesh and Oladele, Rita and Colombo, Arnaldo and Sorrell, Tania and Ramon-Pardo, Pilar and Fusire, Terence and Gigante, Valeria and Sati, Hatim and Morrissey, C Orla and Alffenaar, Jan-Willem and Beardsley, Justin},
  title = {Candida albicans —A systematic review to inform the World Health Organization Fungal Priority Pathogens List},
  journal = {Medical Mycology},
  year = {2024},
  volume = {62},
  number = {6},
  doi = {10.1093/mmy/myae045}
}
Kostenlos starten →